Stryker Corporation

SYK 
(NYSE) 
 
$ 214.10 <%= Resources.Global.txtDown %>
Updated 22/08/2019
Change % -1.91% Stock price decreasing
Change -4.17 Stock price decreasing
Volume 391,939
High $ 219.60
Low $ 212.80
Open $ 218.20
ISIN
Prev close $ 218.27
# of shares 374.10M
Market cap 80,096M USD
Intraday

Market closed
Stryker Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  214.10 -1.3% Stock price decreasing 0.7% Stock price increasing 15.9% Stock price increasing 14.2% Stock price increasing 26.0% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Smith & Nephew PLC ORD USD0.20 1,933.00 1.9% Stock price increasing 9.1% Stock price increasing 16.8% Stock price increasing 34.1% Stock price increasing 40.8% Stock price increasing 32.0% Stock price increasing
 
Johnson & Johnson 127.73 -2.8% Stock price decreasing -2.6% Stock price decreasing -8.0% Stock price decreasing -6.2% Stock price decreasing -6.0% Stock price decreasing -1.0% Stock price decreasing
 
Conmed Corporation 99.29 4.5% Stock price increasing 16.0% Stock price increasing 21.9% Stock price increasing 32.6% Stock price increasing 27.6% Stock price increasing 54.7% Stock price increasing
 
Integra LifeSciences Holdings .. 59.90 -1.8% Stock price decreasing -3.6% Stock price decreasing 22.3% Stock price increasing 7.0% Stock price increasing 1.1% Stock price increasing 32.8% Stock price increasing
 
Zimmer Biomet Hldgs DL-01 124.16 1.7% Stock price increasing 10.9% Stock price increasing 21.8% Stock price increasing 13.2% Stock price increasing 15.7% Stock price increasing 40.7% Stock price increasing
 
NuVasive Inc 63.44 -0.4% Stock price decreasing 7.9% Stock price increasing 3.1% Stock price increasing 9.2% Stock price increasing -9.3% Stock price decreasing 28.0% Stock price increasing

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.

Peers

Instruments Last Change  
Smith & Neph.. 1,933.00 0.2% Stock price increasing
Johnson & Jo.. 127.73 -2.7% Stock price decreasing
Conmed Corpo.. 99.29 -1.6% Stock price decreasing
71,78,75,100,37,50,37,32,12,0
Integra Life.. 59.90 -2.6% Stock price decreasing
67,84,67,37,31,22,2,7,3,2
Zimmer Biome.. 124.16 0.4% Stock price increasing
0,0,0,0,0,100,100,100,100,100
NuVasive Inc 63.44 -2.9% Stock price decreasing
100,74,66,45,31,33,23,2,4,15

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 August 2019 08:44:01
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB6 - 2019-08-25 09:44:01 - 2019-08-25 08:44:01 - 1000 - Website: OKAY